Japan Clinical Laboratory Tests Market Size & Outlook
Japan clinical laboratory tests market, 2018-2030 (US$M)
Related Markets
Japan clinical laboratory tests market highlights
- The Japan clinical laboratory tests market generated a revenue of USD 3,122.8 million in 2023 and is expected to reach USD 6,453.4 million by 2030.
- The Japan market is expected to grow at a CAGR of 10.9% from 2024 to 2030.
- In terms of segment, hba1c tests was the largest revenue generating type in 2023.
- HbA1c tests is the most lucrative type segment registering the fastest growth during the forecast period.
Clinical laboratory tests market data book summary
| Market revenue in 2023 | USD 3,122.8 million |
| Market revenue in 2030 | USD 6,453.4 million |
| Growth rate | 10.9% (CAGR from 2023 to 2030) |
| Largest segment | Hba1c tests |
| Fastest growing segment | HbA1c tests |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
| Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Other key industry trends
- In terms of revenue, Japan accounted for 2.7% of the global clinical laboratory tests market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical laboratory tests market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 5,145.7 million by 2030.
Hba1c tests was the largest segment with a revenue share of 12.03% in 2023. Horizon Databook has segmented the Japan clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
Geographic expansion strategies implemented in the Asia Pacific market by major U.S.-based players to strengthen their position are anticipated to drive market growth in Japan. For instance, in June 2022, LabCorp expanded its central laboratory presence and drug development capabilities in Japan through an expansion of the CB Trial Laboratory.
Moreover, in January 2020, Sysmex Corporation announced an agreement to capitalize in Astrego Diagnostics AB. With this investment, the company intends to help commercialize a drug susceptibility test which is developed by Astrego Diagnostics AB for UTI. Such expansions are likely to boost the market in Japan.
The MHLW Japan controls the reimbursement scenario in Japan. Japan launched a modernized list of reimbursement prices, along with devices and tests that are reimbursed. Most of the tests are performed in hospitals; over 50% of the clinical testing market is hospital-based.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Laboratory Tests Market Scope
Clinical Laboratory Tests Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan clinical laboratory tests market size, by type, 2018-2030 (US$M)
Japan Clinical Laboratory Tests Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
